investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

EGFR T790M-mediated drug resistance in non-small cell lung cancer

Pinar Ozden Eser

0 Collaborator(s)

Funding source

National Institutes of Health (NIH)

Pinar Ozden Eser

Harvard University

Cambridge, United States

Related projects

Bruce E. Johnson

EGFR Mutations in Non-Small Cell Lung Cancer

Trachea, bronchus and lung

Saikrishna Yendamuri

MicroRNA profiling to predict recurrence after resection of early lung cancer

Trachea, bronchus and lung

David Macpherson

Interrogation of MLL2 as a tumor suppressor gene in lung cancer

Trachea, bronchus and lung

Ruth E Malone

Investigating Institutional Influences on Tobacco Control

Trachea, bronchus and lung

Mark Edward Hatley

Dissection of microRNA-21s role in non-small cell lung cancer

Trachea, bronchus and lung

Pediatric oncology or childhood cancer

Eric B. Haura

AN ACTIVE ROLE OF ADAPTOR PROTEINS IN TYROSINE KINASE INHIBITOR RESISTANCE

Trachea, bronchus and lung

Bingliang Fang

Overcoming Resistance to Anti-EGFR Therapy by Drug Repurposing

Trachea, bronchus and lung

Markus Muschen

Negative Feedback Signaling in Tyrosine Kinase-Driven Leukemia

Trachea, bronchus and lung

Roy A Jensen

e-Decidete: Mobile Cessation Support for Latino Smokers in Mexico

Trachea, bronchus and lung